Shopping Cart
Remove All
  • TargetMol
    Your shopping cart is currently empty

Thr-Leu

😃Good
Catalog No. TP3965Cas No. 50299-12-2
Alias Thr-Leu, L-Threonyl-L-leucine, H-Thr-Leu-OH

Thr-Leu is a dipeptide composed of threonine and leucine that can be hydrolyzed in the peritoneal cavity to release its constituent amino acids, thereby increasing dialysate osmotic pressure, and it is used in kinetic and formulation studies of amino acid–based peritoneal dialysis fluids.

Thr-Leu

Thr-Leu

😃Good
Purity: 99.73%
Catalog No. TP3965Alias Thr-Leu, L-Threonyl-L-leucine, H-Thr-Leu-OHCas No. 50299-12-2
Thr-Leu is a dipeptide composed of threonine and leucine that can be hydrolyzed in the peritoneal cavity to release its constituent amino acids, thereby increasing dialysate osmotic pressure, and it is used in kinetic and formulation studies of amino acid–based peritoneal dialysis fluids.
Pack SizePriceUSA WarehouseGlobal WarehouseQuantity
1 mg$29-In Stock
5 mg$47-In Stock
10 mg$66-In Stock
25 mg$113-In Stock
Add to Cart
Add to Quotation
In Stock Estimated shipping dateUSA Warehouse[1-2 days] Global Warehouse[5-7 days]
All TargetMol products are for research purposes only and cannot be used for human consumption. We do not provide products or services to individuals. Please comply with the intended use and do not use TargetMol products for any other purpose.
Questions
TargetMol
View More

Batch Information

Select Batch
Purity:99.73%
Contact us for more batch information

Resource Download

Product Introduction

Bioactivity
Description
Thr-Leu is a dipeptide composed of threonine and leucine that can be hydrolyzed in the peritoneal cavity to release its constituent amino acids, thereby increasing dialysate osmotic pressure, and it is used in kinetic and formulation studies of amino acid–based peritoneal dialysis fluids.
In vitro
Method: Four-hour peritoneal dwell studies in rats were performed using Thr-Leu dipeptide solutions at 8 or 16 mmol/L and compared with a 1.1% amino acid solution, with kinetic modeling of hydrolysis and transport.
Result: Dipeptide solutions showed slower peritoneal volume reduction than amino acid solution, with hydrolysis rates independent of concentration and diffusive transport rates exceeding hydrolysis rates[1].
SynonymsThr-Leu, L-Threonyl-L-leucine, H-Thr-Leu-OH
Chemical Properties
Molecular Weight232.28
FormulaC10H20N2O4
Cas No.50299-12-2
Smiles[C@H](NC([C@H]([C@@H](C)O)N)=O)(CC(C)C)C(O)=O
ColorWhite
AppearanceSolid
SequenceH-Thr-Leu-OH
Sequence ShortTL
Storage & Solubility Information
Storagekeep away from moisture | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature.
Solubility Information
H2O: 100 mg/mL (430.51 mM), Sonication is recommended.
DMSO: 100 mg/mL (430.51 mM), Sonication is recommended.
Solution Preparation Table
H2O/DMSO
1mg5mg10mg50mg
1 mM4.3051 mL21.5257 mL43.0515 mL215.2574 mL
5 mM0.8610 mL4.3051 mL8.6103 mL43.0515 mL
10 mM0.4305 mL2.1526 mL4.3051 mL21.5257 mL
20 mM0.2153 mL1.0763 mL2.1526 mL10.7629 mL
50 mM0.0861 mL0.4305 mL0.8610 mL4.3051 mL
100 mM0.0431 mL0.2153 mL0.4305 mL2.1526 mL

Calculator

  • Molarity Calculator
  • Dilution Calculator
  • Reconstitution Calculator
  • Molecular Weight Calculator

In Vivo Formulation Calculator (Clear solution)

Please enter your animal experiment information in the following box and click Calculate to obtain the stock solution preparation method and in vivo formula preparation method:
TargetMol | Animal experimentsFor example, your dosage is 10 mg/kg Each animal weighs 20 g, and the dosage volume is 100 μL . TargetMol | Animal experiments A total of 10 animals were administered, and the formula you used is 5% TargetMol | reagent DMSO+30% PEG300+5% Tween 80+60% Saline/PBS/ddH2O. So your working solution concentration is 2 mg/mL。
Stock solution preparation method: 2 mg of drug dissolved in 50 μL DMSOTargetMol | reagent (stock solution concentration of 40 mg/mL), if you need to configure a concentration that exceeds the solubility of the product, please contact us first.
Preparation method for in vivo formula: Take 50 μL DMSOTargetMol | reagent main solution, add 300 μLPEG300TargetMol | reagent mix well and clarify, then add 50 more μL Tween 80, mix well and clarify, then add 600 more μLSaline/PBS/ddH2OTargetMol | reagent mix well and clarify
The above example illustrates how to use "In Vivo Formulation Calculator" and does not represent a recommended formulation for any specific compound. Please select an appropriate dissolution method based on your experimental animals and route of administration.
All types of co-solvents required for the protocol, such asDMSO, PEG300/ PEG400, Tween 80, SBE-β-CD, corn oil are available for purchase on the TargetMol website with a simple click.
1 Enter information below:
mg/kg
g
μL
2 Enter the in vivo formulation:
% DMSO
%
% Tween 80
% Saline/PBS/ddH2O

Dose Conversion

You can also refer to dose conversion for different animals. More Dose Conversion

Tech Support

Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc
Related Tags: buy Thr-Leu | purchase Thr-Leu | Thr-Leu cost | order Thr-Leu | Thr-Leu chemical structure | Thr-Leu in vitro | Thr-Leu formula | Thr-Leu molecular weight